AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Salarius Pharmaceuticals, Inc. Director's Dealing 2018

Jun 18, 2018

Director's Dealing

Opens in your device viewer

Issuer: Flex Pharma, Inc. (FLKS)
CIK: 0001615219
Period of Report: 2018-06-14

Reporting Person: McCabe John P. (Chief Financial Officer)

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-06-14	Stock Option (right to buy)	$1.35	A	179848	Acquired	2028-06-14	Common Stock (179848.0)	Direct

F1: The stock option will vest in 48 successive equal monthly installments measured from June 14, 2018.